"Visit the UCLA Health website for coronavirus updates."

During the past decade, Mattel Children's Hospital, UCLA conducted 63 clinical trials. In the 10-year time frame, 63 clinical trials started and 31 clinical trials were completed, i.e. on average, 49.2% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 18 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mattel Children's Hospital, UCLA" #1 sponsor was "Children's Oncology Group" with 36 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 33 trials sponsored, "National Cancer Institute (NCI)" with 25 trials sponsored, "University of California, Los Angeles" with 7 trials sponsored and "Boston Children's Hospital" with 7 trials sponsored. Other sponsors include 44 different institutions and companies that sponsored additional 41 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mattel Children's Hospital, UCLA" #1 collaborator was "National Cancer Institute (NCI)" with 37 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 15 trials as a collaborator, "Glaxo Wellcome" with 6 trials as a collaborator, "Bristol-Myers Squibb" with 5 trials as a collaborator and "Children's Oncology Group" with 4 trials as a collaborator. Other collaborators include 75 different institutions and companies that were collaborators in the rest 62 trials.

According to Clinical.Site data, the most researched conditions in "Mattel Children's Hospital, UCLA" are "HIV Infections" (35 trials), "Pregnancy" (10 trials), "Recurrent Osteosarcoma" (10 trials), "Recurrent Neuroblastoma" (9 trials) and "Refractory Neuroblastoma" (9 trials). Many other conditions were trialed in "Mattel Children's Hospital, UCLA" in a lesser frequency.

Most popular intervention types in "Mattel Children's Hospital, UCLA" are "Drug" (102 trials), "Other" (50 trials), "Biological" (26 trials), "Procedure" (23 trials) and "Radiation" (19 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (23 trials), "Cyclophosphamide" (19 trials), "Vincristine Sulfate" (18 trials), "Zidovudine" (17 trials) and "Radiation Therapy" (14 trials). Other intervention names were less common.

The vast majority of trials in "Mattel Children's Hospital, UCLA" are 137 trials for "All" genders, 9 trials for "Male" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "Mattel Children's Hospital, UCLA". undefined are not yet recruiting, 34 are recruiting, 29 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 75 completed trials in Mattel Children's Hospital, UCLA, 2 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Mattel Children's Hospital, UCLA, 18 "Phase 1" clinical trials were conducted, 50 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 12 trials that are defined as “Not Applicable".